Reply
- PMID: 33381916
- DOI: 10.1002/art.41633
Reply
Comment on
-
Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity.Arthritis Rheumatol. 2020 Nov;72(11):1953-1955. doi: 10.1002/art.41409. Epub 2020 Sep 22. Arthritis Rheumatol. 2020. PMID: 32564467 Free PMC article. No abstract available.
-
Antiphospholipid Autoantibodies and Thrombosis in Patients With COVID-19: Comment on the Article by Bertin et al.Arthritis Rheumatol. 2021 May;73(5):897-899. doi: 10.1002/art.41634. Epub 2021 Mar 16. Arthritis Rheumatol. 2021. PMID: 33381888 No abstract available.
References
-
- Piazza G, Morrow DA. Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA 2020;324:2548-9.
-
- Chayoua W, Kelchtermans H, Moore GW, Gris JC, Musial J, Wahl D, et al. Detection of anti-cardiolipin and anti-β2glycoprotein I antibodies differs between platforms without influence on association with clinical symptoms. Thromb Haemost 2019;119:797-806.
-
- Chamley LW, McKay EJ, Pattison NS. Cofactor dependent and cofactor independent anticardiolipin antibodies. Thromb Res 1991;61:291-9.
-
- Pellegrino NM, Caccavo D. Variability in anticardiolipin antibody detection: role of nonspecific IgG binding and different microtiter plates. Clin Appl Thromb Hemost 2007;13:404-9.
-
- Martirosyan A, Aminov R, Manukyan G. Environmental triggers of autoreactive responses: induction of antiphospholipid antibody formation [review]. Front Immunol 2019;10:1609.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
